Blood-based biomarkers of inflammation and immunosuppressant metabolism in patients undergoing liver transplant
LT Inflammation and Immunosuppression Biomarkers
Sponsor: American Association for the Study of Liver Diseases and American Philosophical Society
Enrolling: Male and Female Patients
IRB Number: AAAV5100
Contact: Transplant Clinical Research Center: 212-305-3839 / tcrcstudyreferral@cumc.columbia.edu
Additional Study Information: A complication that can occur after liver transplant (LT) is rejection, in which the patient's immune system damages the transplanted liver. This complication can be prevented with immunosuppressant medications, which are routinely used after LT. The main purpose of this study is to determine if bacteria in the intestine (gut microbiome) may affect the body's immune system activation, inflammation, and processing of immunosuppressant medications. If you have any questions regarding this study, please contact the Transplant Clinical Research Center (TCRC).
Investigator
Yael Nobel, MD, MS
Do You Qualify?
Are you at least 18 years of age? Yes No
Have you undergone a liver transplant within the last 30 days? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder


CAPTCHA
Image CAPTCHA
Enter the characters shown in the image.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Cancel
For more information, please contact:
Transplant Clinical Research Center
tcrcstudyreferral@cumc.columbia.edu
212-305-3839
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE